EZH2 expression was not significantly associated with EFS or OS in the whole cohort (HR 1.59, p = 0.173 and HR 1.57; p = 0.215, respectively), nor in DLBCL-NOS (HR 1.69, p = 0.153 and HR 1.56, p = 0.882, respectively). Here, EZH2 is linked to diffuse large B-cell lymphoma.